Safety and Efficacy of Propionate for Reduction of LDL Cholesterol

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
62 patients with low cardiovascular risk will be 1:1 randomized to receive either placebo (b.i.d.) or 500mg of propionate (b.i.d.). The primary endpoint is the change (delta) in blood LDL cholesterol levels after 8 weeks.
Epistemonikos ID: 3dde904754092d462d925858d487be92bb141339
First added on: May 21, 2024